Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults

Gallant, Joel; Brunetta, Jason; Crofoot, Gordon; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 73(3):294-298, November 1, 2016.

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study

Mills, Anthony; Crofoot, Gordon Jr; McDonald, Cheryl; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 69(4):439-445, August 1, 2015.

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF...

Wohl, David A.; Cohen, Calvin; Gallant, Joel E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 65(3):e118-e120, March 1, 2014.

A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil...

Zolopa, Andrew; Sax, Paul E.; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(1):96-100, May 1, 2013.

Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients: Randomized, Open-Label Pilot Study

Mills, Anthony; Mildvan, Donna; Podzamczer, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 62(2):164-170, February 1, 2013.